Philips North America

Trials

250 participants · First posted Feb 4, 2025

Terminated

NCT02351726

Mitroflow DL Post Approval Study- North America

186 participants · First posted Jan 30, 2015

Terminated

NCT02233855

People Presenting With Neurocysticercosis in North America

11 participants · First posted Sep 9, 2014

Drugs

View all 101 →

Small Molecule

Investigational

North-methanocarbathymidine

C₁₂H₁₆N₂O₄

CD26 antigen inhibitors (America Stem Cell)

Acellular pertussis vaccine (North American Vaccine)

Organizations

View all 352 →

NUTRICIA NORTH AMERICA

United States

SGS NORTH AMERICA

United States

DANONE NORTH AMERICA

United States

News

View all 2455 →

29 days ago

ARPA-H Awards $31.1M to Siemens Healthineers for Autonomous Endovascular Stroke Robotics

9 months ago

TempraMed Expands Temperature-Controlled Medication Storage Solutions Across Europe and North America

6 months ago

Trials

WRAP North America

Mitroflow DL Post Approval Study- North America

People Presenting With Neurocysticercosis in North America

Drugs

North-methanocarbathymidine

CD26 antigen inhibitors (America Stem Cell)

Acellular pertussis vaccine (North American Vaccine)

Organizations

NUTRICIA NORTH AMERICA

SGS NORTH AMERICA

DANONE NORTH AMERICA

News

ARPA-H Awards $31.1M to Siemens Healthineers for Autonomous Endovascular Stroke Robotics

TempraMed Expands Temperature-Controlled Medication Storage Solutions Across Europe and North America

Ipsen Names Michelle Werner as North America President to Drive Growth Strategy